Literature DB >> 24805969

Impaired functional capacity in potential liver transplant candidates predicts short-term mortality before transplantation.

Maggie M G Ow1, Paul Erasmus, Gary Minto, Richard Struthers, Moby Joseph, Aileen Smith, Usama M Warshow, Matthew E Cramp, Tim J S Cross.   

Abstract

Liver transplantation (LT) is a lifesaving treatment. Because of the shortage of donor organs, some patients will not survive long enough to receive a transplant. The identification of LT candidates at increased risk of short-term mortality without transplantation may affect listing decisions. Functional capacity, determined with cardiopulmonary exercise testing (CPET), is a measure of cardiorespiratory reserve and predicts perioperative outcomes. This study examined the association between functional capacity and short-term survival before LT and the potential for CPET to predict 90-day mortality without transplantation. A total of 176 patients who were assessed for nonacute LT underwent CPET. Ninety days after the assessment, 10 of the 164 patients who had not undergone transplantation were deceased (mortality rate = 6.1%). According to a comparison of survivors and nonsurvivors, the Model for End-Stage Liver Disease score, UK Model for End-Stage Liver Disease (UKELD) score, age, anaerobic threshold, and peak oxygen uptake (VO(2)) were significant univariate predictors of 90-day mortality without transplantation, but only the UKELD score and peak VO(2) retained significance in a multivariate analysis. The mean peak VO(2) was significantly lower for nonsurvivors versus survivors (15.2 ± 3.3 versus 21.2 ± 5.3 mL/minute/kg, P < 0.001). According to a receiver operating characteristic (ROC) curve analysis, peak VO(2) performed well as a diagnostic test (area under the ROC curve = 0.84, 95% confidence interval = 0.76-0.92, sensitivity = 0.90, specificity = 0.74, P < 0.001). The optimal cutoff value for predicting mortality was ≤17.6 mL/minute/kg. The positive predictive value of a peak VO(2)  ≤ 17.6 mL/minute/kg for 90-day mortality was greatest for patients with high UKELD scores: 38% of the patients with a UKELD score ≥ 57 and a peak VO(2)  ≤ 17.6 mL/minute/kg died, whereas only 6% of the patients with a UKELD score ≥ 57 and a peak VO(2)  > 17.6 mL/minute/kg died (P = 0.03). In conclusion, patients assessed for LT with an impaired functional capacity have poorer short-term survival; this is particularly true for individuals with worse liver disease severity.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2014        PMID: 24805969     DOI: 10.1002/lt.23907

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  8 in total

1.  Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.

Authors:  Patrick McCabe; Artin Galoosian; Robert J Wong
Journal:  Dig Dis Sci       Date:  2019-10-22       Impact factor: 3.199

2.  Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.

Authors:  Jacqueline B Henson; Yuval A Patel; Julius M Wilder; Jiayin Zheng; Shein-Chung Chow; Lindsay Y King; Andrew J Muir
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

3.  Physical Activity Patterns in Frail and Nonfrail Patients With End-Stage Liver Disease.

Authors:  Shirley Handelzalts; Michael Volk; Jessica D Zendler; Cristine Agresta; Jillian Peacock; Neil B Alexander
Journal:  J Clin Exp Hepatol       Date:  2021-10-23

4.  Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization.

Authors:  Michael A Dunn; Deborah A Josbeno; Amit D Tevar; Vikrant Rachakonda; Swaytha R Ganesh; Amy R Schmotzer; Elizabeth A Kallenborn; Jaideep Behari; Douglas P Landsittel; Andrea F DiMartini; Anthony Delitto
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

Review 5.  Sarcopenia in Patients with Chronic Liver Disease: Can It Be Altered by Diet and Exercise?

Authors:  Matthew R Kappus; Mardeli Saire Mendoza; Douglas Nguyen; Valentina Medici; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2016-08

6.  Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.

Authors:  Lisa B VanWagner; Matthew E Harinstein; James R Runo; Christopher Darling; Marina Serper; Shelley Hall; Jon A Kobashigawa; Laura L Hammel
Journal:  Am J Transplant       Date:  2017-11-18       Impact factor: 8.086

7.  Association of physiological reserve measures with adverse outcomes following liver transplantation.

Authors:  James S Kimber; Richard J Woodman; Sumudu K Narayana; Libby John; Jeyamani Ramachandran; David Schembri; John W C Chen; Kate R Muller; Alan J Wigg
Journal:  JGH Open       Date:  2022-01-12

Review 8.  Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions.

Authors:  Pranab M Barman; Lisa B VanWagner
Journal:  Hepatology       Date:  2021-06       Impact factor: 17.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.